Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News on Pharma

China posts 6-month high COVID count as it sticks with strategy

China on Sunday reported its highest number of new COVID-19 infections in six months, a day after health officials said they were sticking with strict coronavirus curbs, likely disappointing recent investor hopes for an easing.

The COVID drug under a cloud that made billions

The COVID drug under a cloud that made billions

'It's a big deal because the Australian government purchased a huge amount of that drug.'

Newcastle Herald

Regeneron, Bayer offer more promising data for aging eye drug

Bayer AG and Regeneron Pharmaceuticals Inc.’s blockbuster eye drug reached another clinical milestone by showing sustained efficacy in trials that could help the companies push back against a competing product from Roche Holding AG.

Tribune News Service

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

NHS could pay higher drug prices if Brexit trade deal with India goes ahead

India supplies the NHS with a quarter of its medicines and changes to pharma monopoly rights and patent laws under leaked plans could see costs spiral

Public's confidence in vaccines plummets since Covid pandemic

Covid vaccines are estimated to have saved tens of millions of lives during the pandemic

Nine Covid symptoms affecting the fully vaccinated — and signs you may have it

Fainting and fatigue may signal onset of variant, experts say

The Independent UK

Speed pill prices plunge to B2 each

Methamphetamine pills, which cost as much as 300 baht apiece in Thailand just a few years ago, can now be had for as little as two baht each, say police who arrested a drug suspect in Lop Buri.

inkl

Read news from The Economist, FT, and more,
with one subscription

Next-Gen Psychedelic Delivers Promising Results For Treatment-Resistant Depression In Phase 2 Clinical Trial

Next-Gen Psychedelic Delivers Promising Results For Treatment-Resistant Depression In Phase 2 Clinical Trial

Psychedelics biotech company Biomind Labs Inc. (OTC: BMNDF) has announced positive initial results from part 1 of a Phase 2 clinical trial on its proprietary liquid inhaled formulation of DMT, BMND01, designed for Treatment-Resistant Depression (TRD).

LSD Microdosing Yields Positive Outcomes In Phase 1 Study, More Trials On Depression & Existential Distress

LSD Microdosing Yields Positive Outcomes In Phase 1 Study, More Trials On Depression & Existential Distress

Holding company Blackhawk Growth Corp.(OTC: BLRZF)'s subsidiary company MindBio Therapeutics Pty Ltd shared the positive data gathered from its

High court to hear water dispute between Navajo, government

High court to hear water dispute between Navajo, government

The Supreme Court will hear a water dispute involving the U.S. government and the Navajo Nation

The Independent UK

Looking for Passive Income? Try This Monster Stock

Looking for Passive Income? Try This Monster Stock

Leading biopharmaceutical company AbbVie Inc. (ABBV) is well-positioned to benefit from its diversified portfolio, research breakthroughs, drug and therapy approvals, acquisitions, and partnerships. The company has been increasingly paying dividends, supported by its stable earnings stream. Therefore, investors looking for passive income amid uncertain market conditions could invest in this…

An epidemic of fentanyl misinformation

An epidemic of fentanyl misinformation

More politicians say fentanyl should be deemed a "weapon of mass destruction." Do they even understand what it is?

Europe OK's 1st one-dose drug to protect babies against RSV

Europe OK's 1st one-dose drug to protect babies against RSV

The European Commission has authorized the world’s first one-dose drug against a respiratory virus that sickens millions of babies and children globally every year

The Independent UK

‘Vaccine apathy’ slowing down London’s Covid booster rollout

‘Vaccine apathy’ slowing down London’s Covid booster rollout

Top health professor warns that over-50s in London must be better protected heading into winter

Evening Standard

Get all your
news in one place.

100's of premium titles.
One news app.

Healthtech and sustainable start-ups win Scottish innovation awards

Rebecca Goss from the University of St Andrews, who founded X-Genix, takes overall prize

The Independent UK

Pfizer study says updated COVID boosters rev up protection

Pfizer says its updated COVID-19 booster significantly revved up adults' virus-fighting antibodies

The Independent UK

How long can you test positive for Covid and when are you infectious?

A surge in cases is indicating a new wave has started in the UK

The Independent UK

Nine Covid symptoms affecting the fully vaccinated — and signs you may have it

Fainting and fatigue may signal onset of variant, experts say

Get all your
news in one place.

100's of premium titles.
One news app.

China to make 'substantial' COVID policy changes soon - ex-govt expert

China will make substantial changes to its "dynamic-zero" COVID-19 policy in coming months, a former Chinese disease control official told a conference hosted by Citi on Friday, according to a recording of the session heard by Reuters.

China's COVID policies are consistent and clear - China foreign ministry

Chinese foreign ministry spokesman Zhao Lijian said on Friday that he was not aware of the media report that said China was preparing a plan to end COVID-19 flight suspensions.

The Guardian - US

General Mills latest to halt Twitter ads as Musk takeover sparks brand exodus

Cheerios and Lucky Charms cereal company joins General Motors Co and Audi among others in pulling money from the platform

All the latest COVID-19 news and case numbers from around the states and territories

Here's a quick wrap of the COVID-19 news and case numbers from each Australian jurisdiction from the past week.

The Independent UK

US agency softens opioid prescribing guidelines for doctors

The nation’s top public health agency has revised its guidelines for U.S. doctors prescribing oxycodone and other opioid painkillers

The Independent UK

New York could get $524M under opioid settlements with Teva

New York Attorney General Letitia James says the state will receive up to $524 million from drugmaker Teva to settle claims that the company contributed to the U.S. opioid epidemic

Pfizer, BioNTech start COVID-flu combination vaccine study

U.S. drugmaker Pfizer Inc and its German partner BioNTech SE have started an early-stage study to evaluate a combination vaccine targeting COVID-19 and influenza, the companies said on Thursday.

1 … 104 105 106 107

People

Mangeet Kaur BounsMangeet

Nathan Bartlett

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Organisations

European Commission

Department of Homeland Security

University of Newcastle

inkl

Read news from The Economist, FT, and more,
with one subscription

Topics

140,698 stories

Places

354,333 stories

134,579 stories

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play